loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 21959 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    CONCORDIA PHARMS INC

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 CONCORDIA PHARMS INC (3)

    filter

    01 TABLET, ORALLY DISINTEGRATING;ORAL (3)

    filter

    01 RX (3)

    filter

    01 ORAPRED ODT (3)

    filter

    01 Yes (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Canada
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      PREDNISOLONE SODIUM PHOSPHATE

      PDF Supplier PDF
      URL Supplier Web Content
      TABLET, ORALLY DIS...
      EQ 30MG BASE
      2006-06-01
      21959
      ORAPRED ODT
      RX
      Yes
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag Canada
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        PREDNISOLONE SODIUM PHOSPHATE

        PDF Supplier PDF
        URL Supplier Web Content
        TABLET, ORALLY DIS...
        EQ 10MG BASE
        2006-06-01
        21959
        ORAPRED ODT
        RX
        Yes
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag Canada
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          PREDNISOLONE SODIUM PHOSPHATE

          PDF Supplier PDF
          URL Supplier Web Content
          TABLET, ORALLY DIS...
          EQ 15MG BASE
          2006-06-01
          21959
          ORAPRED ODT
          RX
          Yes
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content

          Looking for FDA Orange Book APPLICATION 21959

          Looking for FDA Orange Book APPLICATION 21959 3

          19

          CONCORDIA PHARMS INC, based in Canada, is a pharmaceutical company.

          One of their notable products is PREDNISOLONE SODIUM PHOSPHATE, with a corresponding application number 21959.

          Regulatory Information RX

          With a dosage strength EQ 30MG BASE

          Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL

          Reference Listed Drug Yes

          Approved since 2006-06-01

          18

          CONCORDIA PHARMS INC, based in Canada, is a pharmaceutical company.

          One of their notable products is PREDNISOLONE SODIUM PHOSPHATE, with a corresponding application number 21959.

          Regulatory Information RX

          With a dosage strength EQ 10MG BASE

          Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL

          Reference Listed Drug Yes

          Approved since 2006-06-01

          17

          CONCORDIA PHARMS INC, based in Canada, is a pharmaceutical company.

          One of their notable products is PREDNISOLONE SODIUM PHOSPHATE, with a corresponding application number 21959.

          Regulatory Information RX

          With a dosage strength EQ 15MG BASE

          Dosage Form Route TABLET, ORALLY DISINTEGRATING; ORAL

          Reference Listed Drug Yes

          Approved since 2006-06-01

          Post Enquiry
          POST ENQUIRY